In addition, histological and immunohistochemical data showed strong nuclear fragmentation and decreased Bcl-2 and Ki67 cancer marker levels in tumor tissues from mice treated with CDPs (Figure 3E). This evidence concerns the gene MKI67 and neoplasm.